MSB 7.69% $1.19 mesoblast limited

From the 25/9 announcement - Mesoblast Cardiac Cell Therapy in...

  1. 136 Posts.
    lightbulb Created with Sketch. 25
    From the 25/9 announcement - Mesoblast Cardiac Cell Therapy in Children "
    Full results of this Phase 2b trial will be presented by the trial’s independent
    investigators at an upcoming conference."

    This announcement spells POSITIVE all over 1. Boston Children Hospital believes in it. 2. Presenting the result at a conference should imply good result.

    Though ASX classified this as a non price sensitive but I think this announcement gives investors a lot of confidence.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
0.085(7.69%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.10 $1.20 $1.09 $13.21M 11.37M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.19
 

Sellers (Offers)

Price($) Vol. No.
$1.19 75212 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.